Study On The Financial Risk Analysis Of Continuous Acquisition Medical Enterprises

Over much of the globe merger market,the pharmaceutical industry has always been a hot area.As the mergers and acquisitions volume increases,the number and frequency of the enterprise mergers and acquisitions also increased significantly,which makes part of companies acquisitions behavior showing a continuous trend of mergers and acquisitions,such as Humanwell Healthcare Co.,Ltd,Shinva Medical Instrument and some other enterprises.Coupled with the recent government policies continuously in pharmaceutical industry continuously,pharmaceutical enterprise independent expansion is difficulty.It can be foresee that in the next few years,successive mergers and acquisitions will become an important means for pharmaceutical enterprises to realize their purpose of rapidly expansion.Based on case study method,this paper choose fosunpharma as an example,which is an typical mergers and acquisitions enterprise in the pharmaceutical industry.In the first,this paper have an introduces about the research background and purpose of this thesis,and have an summarizes about relevant research results domestic and overseas.Then,the paper introduces the theory of merger and acquisition and financial risk.Next,the existing financial risks of fosunpharma are identified from the whole and the specific angles,and it is found that there have problems in excessive liability,low asset utilization and others.Finally,based on the analysis of financial risks,the author puts forward control measures to help fosunpharma reduce financial risks and hopes to provide some references for similar enterprises.In this article,the combination of qualitative and quantitative method is used.This paper draw the following conclusions: the method of debt financing and cash payment brings heavy capital risk,which lead to the existence of a greater insolvency risk,The maintenance of cash mainly relies on financing activities.In addition,pharmaceutical has a strong integration capability in business,but the integration capability in assets is weak.